These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9831795)

  • 1. Is prostate-specific antigen a reliable marker of bone metastasisin patients with newly diagnosed cancer of the prostate?
    Gontero P; Muir GH
    Eur Urol; 1998 Dec; 34(6):518-9. PubMed ID: 9831795
    [No Abstract]   [Full Text] [Related]  

  • 2. Procollagen type I carboxyterminal extension peptide in serum: a reliable marker of bone metastatic disease in newly diagnosed prostate cancer?
    Perachino M; Di Ciolo L; Barbetti V; Puppo P
    Eur Urol; 1996; 29(3):366-9. PubMed ID: 8740025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of serum prostate specific antigen and other parameters in detecting bone metastases in prostate cancer.
    Ataus S; Citçi A; Alici B; Onder AU; Sönmezoğlu K; Erözenci A; Solok V
    Int Urol Nephrol; 1999; 31(4):481-9. PubMed ID: 10668943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer.
    Miller PD; Eardley I; Kirby RS
    Br J Urol; 1992 Sep; 70(3):295-8. PubMed ID: 1384920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen level and risk of bone metastasis in Sudanese patients with prostate cancer.
    Khalid KE; Brair AI; Elhaj AM; Ali KE
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1041-3. PubMed ID: 21912047
    [No Abstract]   [Full Text] [Related]  

  • 6. Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?
    Wolff JM; Zimny M; Borchers H; Wildberger J; Buell U; Jakse G
    Eur Urol; 1998; 33(4):376-81. PubMed ID: 9612680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
    Wang ZL; Wang XF
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum osteocalcin in monitoring bone metastases in advanced prostatic cancer.
    Marcellini M; De Carli P; Abbolito MR; Mainiero G; Cantiani R
    Eur Urol; 1992; 21 Suppl 1():102-4. PubMed ID: 1385126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA; Valenzuela H; Morote J; Gelabert A
    Eur J Nucl Med; 1999 Jun; 26(6):625-32. PubMed ID: 10369948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of skeletal alkaline phosphatase and prostate-specific antigen in the diagnosis of bone metastasis in cancer of the prostate.
    Wolff JM; Ittel T; Borchers H; Brauers A; Jakse G
    Urol Int; 1998 Oct; 61(1):12-6. PubMed ID: 9792976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of prostate specific antigen that predict skeletal spread in prostate cancer.
    Pantelides ML; Bowman SP; George NJ
    Br J Urol; 1992 Sep; 70(3):299-303. PubMed ID: 1384921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between bone metabolic markers and bone scan in prostatic cancer.
    Maeda H; Koizumi M; Yoshimura K; Yamauchi T; Kawai T; Ogata E
    J Urol; 1997 Feb; 157(2):539-43. PubMed ID: 8996351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.
    Loeb S; Makarov DV; Schaeffer EM; Humphreys EB; Walsh PC
    J Urol; 2010 Jul; 184(1):157-61. PubMed ID: 20483148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate].
    Morote J; de Torres JA
    Actas Urol Esp; 1990; 14(4):268-70. PubMed ID: 1702258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of biochemical bone metabolism parameters].
    Hegele A; Olbert P; Wahl HG; Hofmann R
    Urologe A; 2007 Sep; 46(9):1285-6. PubMed ID: 17609924
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone scanning--who needs it among patients with newly diagnosed prostate cancer?
    Hirobe M; Takahashi A; Hisasue S; Kitamura H; Kunishima Y; Masumori N; Iwasawa A; Fujimori K; Hasegawa T; Tsukamoto T
    Jpn J Clin Oncol; 2007 Oct; 37(10):788-92. PubMed ID: 17911377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
    Casetta G; Gamba P; Piana P; Pecchio F; Tizzani A
    Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
    Gleave ME; Coupland D; Drachenberg D; Cohen L; Kwong S; Goldenberg SL; Sullivan LD
    Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.